Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Efficacy Testing

Part of paid clinical trials in Houston, Texas.

Sponsor
M.D. Anderson Cancer Center
Study ID
NCT06785441
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
MALE
Age
65 Years - N/A
Healthy Volunteers
Not accepted

Study Details

This protocol describes pilot testing of an educational shared decision-making intervention to help men with localized prostate cancer make decisions with their health care providers about if and when to de-escalate surveillance testing. The project is important because for many patients their cancer does not progress to the point of needed curative treatment or their health status changes such that they are no longer good candidates for treatment. For these men, de-escalating ongoing surveillance (e.g., fewer biopsies or imaging studies) is a reasonable option.

Key Dates

Start date
May 25, 2023
Status verified
Jan 2025
Primary completion
Feb 2, 2027
Completion
Feb 2, 2030

Study Design

Enrollment
180 participants (estimated)

Primary Outcome Measure

Preparation for Decision Making Scale [ Time Frame: Through study completion and average of 1 year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
M.D. Anderson Cancer CenterHoustonTexas77030
Lisa Lowenstein, MD
[email protected]
713-563-0020
Lisa Lowenstein, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Houston, TX

By condition
Prostate cancer
By specialty
OncologyProstate oncologyMen's healthUrology
By research site
M.D. Anderson Cancer Center· Houston, TX

Related Studies